Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_assertion type Assertion NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_head.
- NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_assertion description "[We examined the association between this SLCO1B3 polymorphism and time from ADT to androgen independence, ADT to prostate-specific antigen (PSA) nadir and PSA nadir to androgen independence in 68 Caucasian patients with advanced prostate cancer who were treated with ADT with metastatic disease (D2) or biochemical failure with no metastatic disease (D0).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_provenance.
- NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_assertion evidence source_evidence_literature NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_provenance.
- NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_assertion SIO_000772 18537956 NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_provenance.
- NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_assertion wasDerivedFrom befree-2016 NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_provenance.
- NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_assertion wasGeneratedBy ECO_0000203 NP675439.RAH7YnXYxiCh0pvQuKa37OQ-zwgGIwgp7ToLqsXirqztg130_provenance.